A Pooled Subanalysis of the Efficacy of Certolizumab Pegol in Patients with Self-Reported Psoriatic Arthritis in Ongoing Phase 3 Psoriasis Studies (CIMPASI-1, CIMPASI-2, and CIMPACT)
Document Type
Abstract
Publication Date
9-2018
DOI
10.1016/j.jaad.2018.05.118
Journal Title
Journal of the American Academy of Dermatology
Department
Dermatology
Recommended Citation
Gottlieb, A. B., Merola, J. F., Reich, K., Thaci, D., Coates, L., Drew, J., Burge, D., Peterson, L., Arendt, C., & Kavanaugh, A. (2018). A Pooled Subanalysis of the Efficacy of Certolizumab Pegol in Patients with Self-Reported Psoriatic Arthritis in Ongoing Phase 3 Psoriasis Studies (CIMPASI-1, CIMPASI-2, and CIMPACT). Journal of the American Academy of Dermatology, 79 (3 Suppl.1), AB19. https://doi.org/10.1016/j.jaad.2018.05.118
COinS
